These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 38256370)

  • 1. Differences in Health-Related Quality of Life among Patients with Heart Failure.
    Ventoulis I; Kamperidis V; Abraham MR; Abraham T; Boultadakis A; Tsioukras E; Katsiana A; Georgiou K; Parissis J; Polyzogopoulou E
    Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.
    Chandra A; Vaduganathan M; Lewis EF; Claggett BL; Rizkala AR; Wang W; Lefkowitz MP; Shi VC; Anand IS; Ge J; Lam CSP; Maggioni AP; Martinez F; Packer M; Pfeffer MA; Pieske B; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Zannad F; Zile MR; McMurray JJV; Solomon SD;
    JACC Heart Fail; 2019 Oct; 7(10):862-874. PubMed ID: 31302043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of baseline parameters on one-year physical, mental, and health-related quality of life in patients with heart failure and preserved ejection fraction.
    Fitz J; Edelmann F; Hasenfuß G; Sandek A; Nolte K; Hashemi D; Trippel TD; Wachter R; Herrmann-Lingen C
    ESC Heart Fail; 2021 Dec; 8(6):4635-4643. PubMed ID: 34480783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
    Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
    ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sense of Coherence as a Mediator Between Functional Status and Health-Related Quality of Life in Patients With Heart Failure.
    Lee HP; Hsu WY; Liu YH; Chang YC; Cheng SM; Chiang HH
    J Nurs Res; 2024 Jan; 32(1):e311. PubMed ID: 38190326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
    Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G
    Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries.
    Johansson I; Joseph P; Balasubramanian K; McMurray JJV; Lund LH; Ezekowitz JA; Kamath D; Alhabib K; Bayes-Genis A; Budaj A; Dans ALL; Dzudie A; Probstfield JL; Fox KAA; Karaye KM; Makubi A; Fukakusa B; Teo K; Temizhan A; Wittlinger T; Maggioni AP; Lanas F; Lopez-Jaramillo P; Silva-Cardoso J; Sliwa K; Dokainish H; Grinvalds A; McCready T; Yusuf S;
    Circulation; 2021 Jun; 143(22):2129-2142. PubMed ID: 33906372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis.
    Taylor RS; Walker S; Ciani O; Warren F; Smart NA; Piepoli M; Davos CH
    Health Technol Assess; 2019 May; 23(25):1-98. PubMed ID: 31140973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 11. Heart failure with preserved, mid-range, and reduced ejection fraction across health care settings: an observational study.
    de Boer AR; Vaartjes I; Gohar A; Valk MJM; Brugts JJ; Boonman-de Winter LJM; van Riet EE; van Mourik Y; Brunner-La Rocca HP; Linssen GCM; Hoes AW; Bots ML; den Ruijter HM; Rutten FH
    ESC Heart Fail; 2022 Feb; 9(1):363-372. PubMed ID: 34889076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
    Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
    JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implications of Functional Mitral Regurgitation Severity in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF).
    Naser N
    Med Arch; 2022 Feb; 76(1):17-22. PubMed ID: 35422569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of transcatheter aortic valve replacement in elderly people with severe aortic stenosis with different types of heart failure.
    Dong M; Wang L; Tse G; Dai T; Wang L; Xiao Z; Liu T; Ren F
    BMC Cardiovasc Disord; 2023 Jan; 23(1):34. PubMed ID: 36653770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices.
    Snipelisky D; Kelly J; Levine JA; Koepp GA; Anstrom KJ; McNulty SE; Zakeri R; Felker GM; Hernandez AF; Braunwald E; Redfield MM
    Circ Heart Fail; 2017 Jun; 10(6):e003878. PubMed ID: 28588021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity.
    Reddy YNV; Rikhi A; Obokata M; Shah SJ; Lewis GD; AbouEzzedine OF; Dunlay S; McNulty S; Chakraborty H; Stevenson LW; Redfield MM; Borlaug BA
    Eur J Heart Fail; 2020 Jun; 22(6):1009-1018. PubMed ID: 32150314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.
    Farmakis D; Tromp J; Marinaki S; Ouwerkerk W; Angermann CE; Bistola V; Dahlstrom U; Dickstein K; Ertl G; Ghadanfar M; Hassanein M; Obergfell A; Perrone SV; Polyzogopoulou E; Schweizer A; Boletis I; Cleland JGF; Collins SP; Lam CSP; Filippatos G
    Eur J Heart Fail; 2023 Jun; 25(6):818-828. PubMed ID: 36974770
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.